Home › Soft Tissue Sarcoma › NCT07470008

Prospective Registry of Histotripsy for Soft Tissue Tumors

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* All adult patients who are treated with histotripsy per standard clinical care at University of California San Francisco (UCSF) are eligible for inclusion in the registry.

Exclusion Criteria:

* Children/minors, and adults who lack decision-making capacity, will be excluded from the registry. Patients who do not consent for inclusion in the registry will also be excluded.

About the study

Histotripsy is a treatment that uses focused ultrasound waves to break down tissue without surgery. The ultrasound waves meet at a specific spot and turn the tissue into liquid. This study is a prospective observational registry of participants receiving histotripsy. The goal of this study is to gather information about the use of histotripsy to confirm it is safe and effective medical procedure.

What is being tested

• Medical Record Review (other)

Sponsor: University of California, San Francisco · Participants: 200 · Started: Jan 29, 2026

Contact the study team

• Ryan Lokken, MD · Phone: 877-827-3222

Official record on ClinicalTrials.gov — NCT07470008

Locations in the U.S.

Conditions

• Soft Tissue Sarcoma

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.